bpc-157 fda approval status not approved peptide Survey: Half of Peptide-Users Aren't Aware of FDA Peptide Reclassification 2026: What
Description
More severe injuries may require the full eight week protocol or extended maintenance dosing

Melanocortin agonists include PT-141 and Melanotan II, while mitochondrial and longevity peptides include MOTS-C and Epithalon

Higher doses (5mg twice weekly) used for severe injuries or accelerated healing timelines

However, the group receiving both AOD9604 and HA showed the most favorable results, suggesting a potential synergistic interaction